Deneb Medical Raises €14.7M for Robotic Spine Surgery

Deneb Medical, a Spanish innovator in surgical robotics, has successfully closed a significant funding round, raising €14.7 million to propel its advanced laser-based robotic system for spinal procedures toward market entry. This substantial capital injection marks a pivotal moment for the San Sebastián-based company as it aims to redefine surgical automation in a sector where precision is paramount.

The investment was spearheaded by the Spanish Society for Technological Transformation (SETT), which contributed €7.2 million. This funding from the state-owned entity, utilizing European Next Generation EU resources, underscores confidence in emerging technology firms. Further bolstering the round, Kutxa Fundazioa, a prominent foundation from the Gipuzkoa region, invested €2.5 million. Adding a significant international dimension, an undisclosed US multinational specializing in medical devices injected €5 million, signaling strategic interest from a major global player in the medtech arena.

At the heart of Deneb Medical's ambition is its flagship development, the IZAR system. This sophisticated platform integrates robotics, advanced photonics, and artificial intelligence, with the ambitious goal of achieving full automation in spinal surgery, moving beyond current assistive technologies. The system promises submillimeter accuracy, employing real-time tissue recognition to guide the precise placement of pedicle screws, thereby enabling highly personalized patient treatments tailored to individual anatomy.

The spinal surgery market is experiencing robust growth, driven by an aging population and increasing demand for minimally invasive procedures. Robotic assistance is becoming standard, enhancing surgeon capabilities and improving patient outcomes. However, Deneb Medical's pursuit of full automation, coupled with its unique laser-based approach and AI-driven tissue identification, positions it to potentially disrupt this established market. The involvement of a major US medical device firm as an investor provides not only capital but also invaluable market access and strategic guidance for navigating the competitive US market, the largest globally for spinal interventions.

With the newly acquired funds, Deneb Medical plans to accelerate the development and eventual market launch of the IZAR system. Expansion of its current team of 22 highly skilled professionals is also a key objective, enabling the company to scale its operations and R&D efforts. The company will also focus on strengthening its operational base at its headquarters in Donostia. While specific timelines for regulatory approval and clinical validation of IZAR remain undisclosed, this Series A funding provides the necessary runway to achieve these critical milestones.

This funding round, characterized by the Spine Market Group as a Series A, highlights the increasing investor appetite for disruptive medtech solutions that promise enhanced precision and efficiency in complex surgical procedures. The strategic backing from SETT, Kutxa Fundazioa, and the US multinational provides Deneb Medical with a strong foundation to navigate the rigorous path from development to commercialization in the highly regulated medical device industry.